Alembic Pharmaceuticals has achieved a remarkable World Record for conducting the Highest Lipid Screenings in a Single Outreach Campaign. The nationwide healthcare initiative successfully screened 28,772 patients, making it the largest lipid screening campaign of its kind and reinforcing the importance of preventive cardiovascular care.

The large-scale screening drive was organized to raise awareness about the risks associated with abnormal cholesterol and lipid levels, which are among the leading contributors to cardiovascular diseases. Through the initiative, healthcare professionals encouraged individuals to undergo timely lipid profile assessments, enabling the early detection of risk factors and facilitating prompt medical intervention.

By promoting preventive healthcare and educating the public about the significance of regular cholesterol screening, the campaign emphasized the role of early diagnosis and lifestyle management in reducing the burden of heart disease. The initiative reflects Alembic Pharmaceuticals’ commitment to advancing public health through awareness, screening, and preventive care.